Newsroom
Company news
Business
15 June 2021
Alvotech reaches primary completion date in its switching study for AVT02, a proposed interchangeable biosimilar to AbbVie's Humira®
Business
08 June 2021
Robert Wessman presented at the Jefferies Global Healthcare Conference
Charity
07 June 2021
Alvotech employees donate to UNICEF Covid relief in India
Business
11 May 2021
Alvotech seeks to end AbbVie’s wrongful monopoly on Humira and bring affordable arthritis treatment to U.S.
Charity
10 May 2021
Alvotech proud sponsor of Reykjavik’s football club KR
Business
25 March 2021
Alvotech disputes AbbVie’s allegations of wrongdoing
Business
15 March 2021
Alvotech completes second round of a US$ 100m private placement
Charity
05 March 2021
Alvotech and sister company Alvogen donate 100 thousand US dollars to UNICEF in combat against COVID-19
Business
02 March 2021
Cipla Gulf and Alvotech expand partnership for commercialization of biosimilars in Australia and New Zealand
Business
25 February 2021
Alvotech Iceland receives Equal Pay Certification
Business
30 December 2020
Ground-breaking for the extension of Alvotech's high-tech centre in Reykjavik
Business
10 December 2020
Alvotech and Fuji Pharma extend biosimilar partnership in Japan
Business
24 November 2020
Alvotech, Alvotech & CCHT Biopharmaceutical and Yangtze River Pharmaceutical agree on an exclusive biosimilar partnership in China
Business
19 November 2020
Alvotech announces that the U.S. FDA and EMA have accepted regulatory submissions for AVT02, a proposed biosimilar to Humira® (adalimumab)
Business
04 November 2020
Alvotech and Cipla partner to ensure access to biosimilars in South Africa
Business
27 October 2020
Alvotech announces private placement financing
Business
22 September 2020
Alvotech and DKSH extend partnership in Asia
Business
05 August 2020
Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market
People
18 May 2020